Health India Positive

COVID-19 offers unique opportunity to transform Maharashtra's private healthcare sector, introduce minimum standards of operation

India’s private healthcare is among the most under-regulated in the world, and for the larger part after independence, there has been no overarching attempt to regulate minimum standards and rates of services.

Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Pfizer CEO says COVID-19 vaccine likely to be ready by October this year; 'will have enough evidence of safety, efficacy'

Pfizer is working with German firm Biontech for several possible vaccines in Europe and the United States, said the report.

Four out of 14 COVID-19 vaccine candidates may enter clinical trials in next three-five months: Health Minister

Health Minister Harsh Vardhan said, "Till the vaccine is not developed, people should use social vaccines like the mask and social distancing."

Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients

On 1 May, Glenmark Pharmaceuticals said it has become the first company in India to receive approval from Drug Controller General of India (DCGI) to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.

Children have milder COVID-19 symptoms, might have lower infectivity and susceptibility than adults

Serological studies are starting to be available on child infection history with some suggesting low rates of infection.

New study suggests PPE made with electroceutical fabric may provide better protection against COVID-19

The electroceutical fabric developed creates a weak electric field that destabilises the viral electrical balance, making it unable to cause infection.

First COVID-19 vaccine to enter human trials is safe, well-tolerated and able to generate immune response against virus

The trial was carried out in 108 healthy adults with the vaccine demonstrating promising results after 28 days.

Clinical trials are showing that Remdesivir can be life-saving drug for COVID-19 infected patients

Remdesivir mimics the genetic material of the coronavirus and prevents new virus copies from being produced.

Remdesivir preliminary results from NIAID trial published; suggest improvement in recovery time from COVID-19

As per the study, the mortality rate by day 14 was 7.1% in the remdesivir group as compared to 11.9% in the placebo group.